Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

ASLAN Pharmaceuticals Limited (ASLN)

1.87   -0.06 (-3.11%) 07-10 16:00
Open: 1.9121 Pre. Close: 1.93
High: 1.93 Low: 1.8301
Volume: 59,286 Market Cap: 46M
ASLAN Pharmaceuticals Limited operates as a clinical-stage oncology and inflammatory disease focused biopharmaceutical company in the United States. It targets diseases that are prevalent in Asia, and orphan indications in the United States and Europe. The company's lead program, varlitinib, is a reversible small molecule pan-human epidermal growth factor receptor (HER), inhibitor that targets the human epidermal growth factor receptors HER1, and HER2, as well as gastric cancer. Its Varlitinib completed a pivotal clinical trial for biliary tract cancer. In addition, the company is developing ASLAN003, an orally active potent inhibitor of human dihydroorotate dehydrogenase that is in Phase II clinical trials to treat acute myeloid leukemia; and ASLAN004, an interleukin 4/interleukin 13 receptor antibody for the treatment of severe atopic dermatitis and asthma.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.934 - 1.944 1.944 - 1.952
Low: 1.804 - 1.817 1.817 - 1.827
Close: 1.852 - 1.871 1.871 - 1.887

Technical analysis

as of: 2020-07-10 4:25:22 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 2.58     One year: 2.92
Support: Support1: 1.73    Support2: 1.44
Resistance: Resistance1: 2.21    Resistance2: 2.50
Pivot: 1.97
Moving Average: MA(5): 1.90     MA(20): 1.95
MA(100): 1.67     MA(250): 1.92
MACD: MACD(12,26): 0.02     Signal(9): 0.05
Stochastic oscillator: %K(14,3): 10.39     %D(3): 13.13
RSI: RSI(14): 47.51
52-week: High: 8.18  Low: 0.35  Change(%): -42.1
Average Vol(K): 3-Month: 12332  10-Days: 6617

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
ASLN has closed above bottom band by 22.3%. Bollinger Bands are 39% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 25 Jun 2020
46 Stocks Moving In Thursday's Mid-Day Session - Benzinga

Thu, 25 Jun 2020
ASLAN Pharmaceuticals (ASLN) Looks Good: Stock Adds 8.7% in Session - Yahoo Finance

Fri, 19 Jun 2020
ASLAN Pharmaceuticals Ltd. (ASLN) Gains As Market Dips: What You Should Know - Yahoo Finance

Thu, 11 Jun 2020
ASLAN Pharmaceuticals Ltd. (ASLN) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

Thu, 04 Jun 2020
Hedge Funds Souring On ASLAN Pharmaceuticals Limited (ASLN) - Yahoo Finance

Mon, 11 May 2020
ASLAN Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate Update - GlobeNewswire

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NasdaqGM
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 38
Shares Float (M) 37
% Held by Insiders
% Held by Institutions 8.68
Shares Short (K) 11
Shares Short P. Month (K) 18

Stock Financials

EPS -0.855
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 0.410
Profit Margin
Operating Margin
Return on Assets (ttm) -42.0
Return on Equity (ttm) -408.1
Qtrly Rev. Growth
Gross Profit (p.s.) 2.101
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio -2.19
PEG Ratio
Price to Book value 4.56
Price to Sales
Price to Cash Flow

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.